Startup profile for Centerline Biomedical: what they do, why they are interesting, stage (growth), industries, and links to our funding articles. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Centerline Biomedical startup funding profile

Cleveland Clinic spinout of IOPS — non-X-ray 3D endovascular surgical navigation.

Stage

growth

Status

private

Coverage

full

Overview

Centerline Biomedical is a Cleveland Clinic spinoff commercializing IOPS, a 3D GPS-like surgical navigation technology for endovascular procedures that aims to reduce reliance on X-ray fluoroscopy. Ohio Life Sciences directory lists 10000 Cedar Ave, Cleveland, OH; additional Renaissance Parkway addresses appear in directories.

Why Centerline Biomedical is interesting

Clinic commercialization path: Intra-Operative Positioning System (IOPS) to improve endovascular outcomes and cut radiation exposure.

Product & use cases

Intra-operative 3D navigation for endovascular surgery without continuous X-ray dependence.

  • Endovascular aneurysm repair navigation
  • Cath lab radiation reduction initiatives

Key facts

  • Cleveland Clinic spinoff
  • Product: IOPS endovascular navigation
  • Goal: improve outcomes and reduce radiation exposure
  • Cleveland, OH HQ / Clinic campus adjacency

Competitive landscape

Edge: Clinic-origin IP focused on radiation-light navigation.

  • Philips / Siemens image guidance incumbent

    Imaging OEM guidance suites.

  • Centerline peers in surgical navigation direct

    Emerging endovascular nav startups.

Industries

Healthtech Deep Tech

FAQs about Centerline Biomedical

Practical answers founders, operators, and investors typically search for.

Cleveland Clinic spinout of IOPS endovascular navigation technology.
Cleveland Clinic spinout of IOPS — non-X-ray 3D endovascular surgical navigation.
Cleveland, OH
No — private as of July 2026.
growth
See investors / fundraisingRounds when disclosed; otherwise company press page.
healthtech, deep-tech
2015
https://www.centerlinebiomedical.com/

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.